NCT02624128 2023-11-13
V-CHANCE
National Cancer Institute, Naples
Phase 2 Unknown
Clinical Trials
12 trialsNCT02499367 2022-03-22
TONIC
The Netherlands Cancer Institute
Phase 2 Unknown
NCT03588533 2018-07-17
HERZUMA-GC
Dong-A University Hospital
Phase 2 Unknown
NCT01100801 2016-06-22
3G
National University Hospital, Singapore
Phase 2 Unknown
NCT02051868 2015-11-04
InterAACT
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT01655628 2012-08-02
GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT01125020 2010-05-18
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
Shanghai Jiao Tong University School of Medicine
Phase NA Unknown
NCT00980603 2009-09-21
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT00454519 2009-02-13
IPHC
Wuhan University
Phase 2 Unknown
NCT00758381 2008-10-10
MAPS
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Phase 2 Unknown
NCT00226473 2006-06-21
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Dermatologic Cooperative Oncology Group
Phase 4 Unknown
NCT00082472 2006-04-18
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
Zivena
Phase 1/2 Unknown